April 24, 2014
On April 22, 2014, The Atlantic published an article featuring the research of Dr. Stephen Ross, Director of the Division of Alcoholism and Drug Abuse at Bellevue Hospital, Clinical Director of the NYU Langone Center of Excellence on Addiction, and Director of the NYU Addiction Psychiatry Fellowship. Dr. Ross’ research, which is conducted at the NYU Bluestone Center for Clinical Research, aims to determine how well psilocybin can alleviate anxiety associated with an advanced cancer diagnosis. Psilocybin is an hallucinogenic compound which occurs naturally in many species of mushrooms. Although data from the study is still being analyzed, anecdotal evidence suggests that the one-time dosing session with psilocybin has had a profound effect on the majority of study participants.
The article, authored by Roc Morin, can be found here: Prescribing Mushrooms for Anxiety